About two weeks after a Chicago federal judge turned down its request for a new trial, pharmaceutical maker GlaxoSmithKline has formally appealed the judicial decisions the company has contended led to a jury improperly awarding $3 million to the widow of a Chicago lawyer who committed suicide by stepping in front of a train in Chicago’s Loop after taking a generic version of Paxil, an antidepressant developed by GSK.
Class actions deleted vs Spokeo, Intelius, others over web search name 'keyword insertion' ad tricks
A federal judge has tossed a cluster of class action lawsuits launched against online personal information listing providers, including Spokeo, Intelius. InstantCheckmate and BeenVerified, saying a web search advertising technique didn’t violate plaintiffs’ rights to control the use of their identity simply by using a person's name in an ad designed to steer people to their online people search products.
A state appeals panel has sided with several insurance companies facing class action complaints from a Chicago-based medical practice specializing in treating neck and back injuries as part of worker compensation claims, saying the clinic has no right under the law to demand insurers pay interest on slow-arriving reimbursements.
Drug manufacturer GlaxoSmithKline is trying to get out from under a $3 million jury judgment, which blamed it for a Chicago lawyer’s suicide, saying a federal judge made multiple mistakes that hamstrung the manufacturer’s defense against the claim its labels failed to warn its anti-depressant drug Paxil and its generic equivalent can lead to suicide.
A federal jury in Chicago has ordered pharmaceutical maker GlaxoSmithKline to pay $3 million to the widow of a Chicago lawyer who committed suicide by jumping in front of a train after taking a generic version of Paxil, an antidepressant developed by GSK, finding the drugmaker should be held responsible for his death, even though it didn’t make the actual medication the lawyer had been taking for about a week before he took his life.
A trial continues this week in Chicago federal court over the question of how much blame should be shouldered by drugmaker GlaxoSmithKline for the death of a Chicago lawyer who committed suicide after taking a generic version of Paxil, an antidepressant developed by GSK. This week, a federal judge denied an attempt by GSK to abruptly end the weeks-long trial and secure a judgment in its favor.
This week, a Chicago federal court will empanel jurors to decide whether pharmaceutical maker GlaxoSmithKline should be made to pay the widow of a Chicago lawyer who committed suicide by jumping in front of a train after taking a generic version of Paxil, an antidepressant developed by GSK, because, the woman claims, the drug’s warning label, which was approved by federal regulators, did not contain enough information on suicide risk, misleading the doctor who prescribed it.
GlaxoSmithKline must face Paxil birth defects claims from out-of-state plaintiffs in Cook County: Panel
Drugmaker GlaxoSmithKline, a United Kingdom-based company whose U.S. operations are headquartered in Philadelphia, will need to face legal action in Cook County court over claims its drug, Paxil, caused birth defects, after an appeals court ruled local state courts have jurisdiction under Illinois law to preside over the lawsuits – even complaints brought by plaintiffs who have no significant connection to Illinois.
Families of victims of a fiery oil-fueled train derailment and explosion that claimed 47 lives in a town on the eastern edge of Canada’s Quebec Province will need to press their wrongful death claims in federal court, after lawyers for Canadian Pacific Railway and other corporate defendants asked to transfer cases from local to federal jurisdiction.